Coherus Oncology Inc (CHRS)

Free Cash Flow

-$243.92M

TTM · Period ending: · USD

CHRS logo

CHRS Free Cash Flow

Latest reported-$243.92M
CHRS TTM Free Cash Flow ($15.05M → -$243.92M)
High-resolution chart · PNG

CHRS free cash flow history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Coherus Oncology Inc Free Cash Flow — Trailing twelve months (TTM) (USD)
Period endingFree Cash Flow (USD)
-243,917,000
-170,573,000
-138,513,000
-90,189,000
-105,866,000
500,000
-20,440,000
-62,019,000
-54,303,000
-153,052,000
-175,170,000
-262,239,000
-245,485,000
-257,387,000
-243,163,000
-195,913,000
-144,917,000
-94,603,000
-38,721,000
46,241,000
78,032,000
136,442,000
146,914,000
132,065,000
140,857,000
95,545,000
26,533,000
-38,367,000
-135,678,000
-183,708,000
-160,055,000
-142,509,000
-142,556,000
-163,556,000
-204,859,000
-265,286,000
-284,409,000
-255,564,000
-259,060,000
-164,479,000
-164,085,000
-158,243,000
-114,154,000
-152,051,000
-95,974,000
-75,636,000
-26,776,000
11,836,000
39,286,000
36,760,000
15,050,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.